Huan Meng, PhD
Affiliations: | 2008-2021 | Department of Medicine, NanoMedicine | University of California, Los Angeles, Los Angeles, CA |
| 2021- | National Center for Nanoscience and Technology, Chinese Academy of Sciences |
Area:
NanoMedicineWebsite:
https://scholar.google.com.tw/citations?user=JSDANEQAAAAJ&hl=en&oi=aoGoogle:
"Huan Meng"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Yuliang Zhao | grad student | 2008 | University of Chinese Academy of Sciences |
| André E. Nel | post-doc | 2008-2021 | UCLA |
Children
Sign in to add trainee| Jiulong Li | post-doc | 2021- | National Center for Nanoscience and Technology, Chinese Academy of Sciences |
| Han Liao | post-doc | 2017-2018 | UCLA |
| Ying Ji | post-doc | 2017-2019 | UCLA |
| Xiao Zhang | post-doc | 2019-2020 |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Feng Z, Qin M, Jiang J, et al. (2025) Iterative Design of a Prodrug Nanocarrier for Cell Cycle Arrest, Immune Modulation, and Enhanced T Cell Infiltration for Colon Cancer Therapy. Nano Letters |
| Yu S, Zhang Y, Zhou Z, et al. (2025) Nanomaterials-Induced Pyroptosis: Advancing Novel Therapeutic Pathways in Nanomedicine. Small Methods. e2401290 |
| Li R, Hua M, Li J, et al. (2024) The safety of trastuzumab deruxtecan (DS-8201) with a focus on interstitial lung disease and/or pneumonitis: A systematic review and single-arm meta-analysis. Cancer |
| Liu X, Zhang X, Li J, et al. (2023) Enrichment of nano delivery platforms for mRNA-based nanotherapeutics. Medical Review (2021). 3: 356-361 |
| Lv X, Lu X, Cao J, et al. (2023) Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors. Science (New York, N.Y.). 381: eabn4180 |
| Hicks MR, Liu X, Young CS, et al. (2023) Nanoparticles systemically biodistribute to regenerating skeletal muscle in DMD. Journal of Nanobiotechnology. 21: 303 |
| Li J, Xiao Y, Zhang Y, et al. (2023) Pulmonary Delivery of Specialized Pro-Resolving Mediators-Based Nanotherapeutics Attenuates Pulmonary Fibrosis in Preclinical Animal Models. Acs Nano |
| Dong S, Feng Z, Ma R, et al. (2023) Engineered Design of a Mesoporous Silica Nanoparticle-Based Nanocarrier for Efficient mRNA Delivery . Nano Letters |
| Su Y, Zhou X, Meng H, et al. (2022) Cost-benefit analysis of nanofertilizers and nanopesticides emphasizes the need to improve the efficiency of nanoformulations for widescale adoption. Nature Food. 3: 1020-1030 |
| Li J, Diamante G, Ahn IS, et al. (2022) Determination of the nanoparticle- and cell-specific toxicological mechanisms in 3D liver spheroids using scRNAseq analysis. Nano Today. 47 |